Back to Screener

Encompass Health Corporation Common Stock (EHC)

Price$105.49

Favorite Metrics

Price vs S&P 500 (26W)-19.39%
Price vs S&P 500 (4W)-0.24%
Market Capitalization$10.46B
P/E Ratio (Annual)18.48x
Indicated Dividend Yield (Annual)0.72%

All Metrics

P/CF (Annual)8.90x
Book Value / Share (Quarterly)$24.38
P/TBV (Annual)5.01x
Indicated Dividend (Annual)$0.76
Revenue Growth (3Y)10.92%
Cash Flow / Share (Quarterly)$4.39
Payout Ratio (TTM)12.56%
Price vs S&P 500 (YTD)-3.49%
Gross Margin (TTM)95.71%
Net Profit Margin (TTM)9.54%
EPS (TTM)$5.54
10-Day Avg Trading Volume1.10M
EPS Excl Extra (TTM)$5.54
Revenue Growth (5Y)10.72%
EPS (Annual)$5.54
Dividend / Share (Annual)$0.71
ROI (Annual)11.49%
Gross Margin (Annual)95.71%
Net Profit Margin (5Y Avg)8.37%
Cash / Share (Quarterly)$1.14
P/E Basic Excl Extra (TTM)18.48x
Revenue Growth QoQ (YoY)9.94%
EPS Growth (5Y)14.24%
P/E Normalized (Annual)18.48x
ROA (Last FY)7.99%
Revenue Growth TTM (YoY)10.46%
EBITD / Share (TTM)$13.70
ROE (5Y Avg)21.78%
Operating Margin (TTM)17.74%
Cash Flow / Share (Annual)$4.39
P/B Ratio4.29x
P/B Ratio (Quarterly)4.38x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)2.17x
Net Interest Coverage (TTM)9.02x
ROA (TTM)8.27%
EPS Growth QoQ (YoY)21.20%
EV / EBITDA (TTM)9.20x
EPS Incl Extra (Annual)$5.54
Current Ratio (Annual)1.08x
Quick Ratio (Quarterly)0.91x
3-Month Avg Trading Volume1.16M
52-Week Price Return1.92%
EV / Free Cash Flow (Annual)29.33x
P/E Incl Extra (TTM)18.48x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$21.30
P/S Ratio (Annual)1.76x
Asset Turnover (Annual)0.84x
52-Week High$127.99
Operating Margin (5Y Avg)15.98%
EPS Excl Extra (Annual)$5.54
CapEx CAGR (5Y)12.52%
Tangible BV CAGR (5Y)12.99%
26-Week Price Return-15.40%
Quick Ratio (Annual)0.91x
13-Week Price Return2.41%
Total Debt / Equity (Annual)1.02x
Current Ratio (Quarterly)1.08x
Enterprise Value$12,881.157
Revenue / Share Growth (5Y)10.20%
Asset Turnover (TTM)0.87x
Book Value / Share Growth (5Y)8.82%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)32.91x
Pretax Margin (Annual)16.06%
Cash / Share (Annual)$1.14
3-Month Return Std Dev31.64%
Gross Margin (5Y Avg)95.49%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)13.70%
EBITDA Interim CAGR (5Y)30.79%
ROE (Last FY)23.22%
Net Interest Coverage (Annual)9.02x
EPS Basic Excl Extra (Annual)$5.54
P/FCF (TTM)23.82x
Receivables Turnover (TTM)9.75x
EV / Free Cash Flow (TTM)29.33x
Total Debt / Equity (Quarterly)1.02x
EPS Incl Extra (TTM)$5.54
Receivables Turnover (Annual)9.75x
ROI (TTM)11.85%
Dividend Growth Rate (5Y)-8.92%
P/S Ratio (TTM)1.76x
Pretax Margin (5Y Avg)13.12%
Revenue / Share (Annual)$58.07
Tangible BV / Share (Annual)$21.30
Forward P/E17.90x
Free OCF CAGR (5Y)8.18%
Price vs S&P 500 (52W)-27.91%
P/E Ratio (TTM)18.48x
EPS Growth TTM (YoY)24.23%
Year-to-Date Return-0.85%
5-Day Price Return-2.85%
EPS Normalized (Annual)$5.54
ROA (5Y Avg)6.31%
Net Profit Margin (Annual)9.54%
Month-to-Date Return8.80%
Cash Flow / Share (TTM)$7.26
EBITD / Share (Annual)$13.70
EPS Growth (3Y)27.08%
Operating Margin (Annual)17.74%
LT Debt / Equity (Annual)0.89x
P/CF (TTM)8.90x
ROI (5Y Avg)8.82%
P/E Excl Extra (TTM)18.48x
LT Debt / Equity (Quarterly)0.89x
EPS Basic Excl Extra (TTM)$5.54
P/TBV (Quarterly)5.01x
Payout Ratio (Annual)12.56%
P/B Ratio (Annual)4.38x
Dividend / Share (TTM)$0.71
Inventory Turnover (TTM)7.31x
Pretax Margin (TTM)16.06%
Book Value / Share (Annual)$24.38
Price vs S&P 500 (13W)1.73%
Net Margin Growth (5Y)3.66%
Dividend Yield (TTM)0.68%
Beta0.79x
P/FCF (Annual)23.82x
Revenue / Share (TTM)$58.25
ROE (TTM)24.48%
52-Week Low$92.77

Analyst Recommendations

Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.38
4.38
4.38
4.38

Industry Peers — Hospitals(2)

SymbolP/E Ratio (Annual)Revenue Growth TTM (YoY)Operating Margin (TTM)ROE (TTM)Price
EHCEncompass Health Corporation Common Stock
18.48x10.46%17.74%24.48%$105.49
SEMSELECT MEDICAL HOLDINGS CORP
13.90x-41.79%6.17%8.62%$16.39
MDPediatrix Medical Group, Inc.
11.14x-4.92%12.00%19.58%$22.21

About

Encompass Health operates a network of inpatient rehabilitation hospitals concentrated in the eastern United States and Texas. The company provides specialized post-acute care services, with inpatient rehabilitation generating the majority of its revenue. These facilities deliver rehabilitative treatment for patients recovering from acute medical events or surgeries.